QT Imaging Holdings, Inc. (QTI) Stock

QT Imaging Holdings, Inc. (QTI) is a Healthcare stock trading at $2.75 (as of 2026-08-20), with a market capitalization of $40.18M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

QT Imaging Holdings, Inc. develops and manufactures an automated breast imaging system for producing high-resolution transmission ultrasound images. Its QT Ultrasound Breast Scanner generates both reflection-mode and transmission-mode views for breast examinations.

Understand QT Imaging Holdings, Inc.: how it makes money

QT Imaging Holdings builds an automated breast imaging system (QT Ultrasound Breast Scanner) that produces high-resolution transmission ultrasound images, and it makes money by manufacturing and selling those scanners.

Even with positive gross margin (43.0%), the company reports a very negative operating margin (-39.4%), which suggests profitability is being held back by operating expense scale relative to current revenue.

Business quality (Weak): Strong signal on unit shipping activity and gross margin, but revenue is reported as 0.0B for the latest period, and no official reportable segments were provided.

Bull case

  • Gross margin is positive: Gross margin for the latest period is 43.0%, which indicates the core product economics are not obviously impaired at the gross level.
  • Shipping activity shows commercialization progress: In the latest period, the company shipped 13.0 "Breast Acoustic Computed Tomography Scanners".

Bear case

  • Operating losses remain large: Operating margin is -39.4% for the latest period, so operating expenses are outweighing gross profit.
  • Revenue scale appears very small: Revenue is reported as 0.0B for the latest period, which limits how much gross profit can translate into operating progress.
Valuation — source: SEC EDGAR (first-party)
Price$2.75
Market Cap$40.18M
Price / Book17.89
Price / Sales1.52
FCF Yield-31.7%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$18.93M
Net Margin-111.4%
Revenue Growth (YoY)103.2%
EPS Growth (YoY)435.7%
FCF Growth (YoY)236.6%
Financial Health — source: SEC EDGAR
Altman Z-Score-1.10 (distress)
Piotroski F-Score6/9 (moderate)
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.6
Industry P/E (Medical Equipment)32.9
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderLynrock Lake LP ($6.78M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEORaluca Dinu
Employees10
CountryUS
IPO Date2024-03-05

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Vivani Medical, Inc. (VANI)
  • Streamex Corp. (STEX)
  • electroCore, Inc. (ECOR)
  • Hyperfine, Inc. (HYPR)
  • Outset Medical, Inc. (OM)
  • NeurAxis, Inc. (NRXS)
  • Precision Optics Corporation, Inc. (POCI)
  • IRIDEX Corporation (IRIX)
QTI earnings history · QTI institutional & insider holders · QTI KPIs & operating metrics · QTI financials · QTI investor presentations & press releases · QTI SEC filings · QTI peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.